Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PHOTOCURABLE ELECTRON DEFICIENT OLEFIN-CONTAINING COMPOSITIONS
Document Type and Number:
WIPO Patent Application WO/2017/151711
Kind Code:
A1
Abstract:
This invention relates to photocurable electron deficient olefin-containing compositions, such as those containing certain 2-cyanoacrylates, 2-cyanopentadienoates, methylidene malonates, and vinylidine cyanide, and photolatent bases. When exposed to radiation in the electromagnetic spectrum, the compositions show a delay cure property.

Inventors:
WOODS JOHN G (US)
PALLIARDI MARY (US)
SCHALL JOEL D (US)
JACOBINE ANTHONY F (US)
Application Number:
PCT/US2017/020099
Publication Date:
September 08, 2017
Filing Date:
March 01, 2017
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
HENKEL IP & HOLDING GMBH (DE)
WOODS JOHN G (US)
International Classes:
C08F4/00; C08F2/46; C08F22/32; C09J4/04
Foreign References:
US5691113A1997-11-25
US20140238603A12014-08-28
US6965040B12005-11-15
Other References:
See also references of EP 3423499A4
Attorney, Agent or Firm:
BAUMAN, Steven C. et al. (US)
Download PDF:
Claims:
WHAT IS CLAIMED IS:

1. A photocurable composition comprising:

(a) An electron deficient olefin; and

(b) A photolatent base.

2. The composition of Claim 1, wherein the electron deficient olefin is a member selected from the group consisting of 2- cyanoacrylates, 2-cyanopentadienoates , methylidene malonates, and vinylidine cyanide.

3. The composition of Claim 2, wherein the 2-cyanoacrylate is a member selected from the group consisting of mono-functional 2-cyanoacrylates, di-functional cyanoacrylates , poly-functional 2-cyanoacrylates and combinations thereof.

4. The composition of Claim 2, wherein the 2-cyanoacrylate is within the following structure:

wherein in this connection R1 is selected from C1-16 alkyl, C2-16 alkoxyalkyl, C3-16 cycloalkyl, C2-16 alkenyl, C2-16 alkynyl, C5-16 aryl, C7-16 arylalkyl, or C1-16 haloalkyl groups.

5. The composition of Claim 2, wherein the 2-cyanoacrylate is selected from methyl cyanoacrylate, ethyl-2-cyanoacrylate , propyl cyanoacrylates, butyl cyanoacrylates, octyl

cyanoacrylates, allyl cyanoacrylate, β-methoxyethyl

cyanoacrylate and combinations thereof. The composition of Claim 2, wherein the methylidene lonate is within the following structure:

wherein in this connection R2 and R3 are each independently selected from C1-16 alkyl, alkoxyalkyl, cycloalkyl, alkenyl, aralkyl, aryl, allyl or haloalkyl groups.

7. The composition of Claim 1, wherein the photolatent base is within the following structure:

wherein X is X is any one of hydrogen, alkyl, hydroxyl, thiol or heteroalkyl, Y is an alkylene linkage, Ra is an alkyl group having from one to four carbon atoms or an alkenyl group having from two to four carbon atoms, Rb is an alkyl group having from one to four carbon atoms or an alkenyl group having from two to four carbon atoms, Rc is an alkyl group having from one to four carbon atoms or an alkenyl group having from two to four carbon atoms, or Rb and Rc taken together form a cyclic ring structure of three to seven ring atoms, which may be interrupted by one or more heteroatoms, and n is 0 or 1.

The composition of Claim 1, wherein the photolatent base member selected from the group consisting of [ (a-methyl-2- nitrobenzyl) oxycarbonyl] morpholine, [ (2-nitrobenzyl ) oxycarbonyl] dimethylamine, and 2- ( 2-nitrophenyl ) propoxycarbonyl piperidine.

9. The composition of Claim 1, further comprising a stabilizer package comprising at least one of a free radical stabilizer and an anionic stabilizer.

10. The composition of Claim 1, further comprising one or more additives selected from the group consisting of cure

accelerators, thickeners, thixotropes, tougheners, thermal resistance-conferring agents, and plasticizers .

11. The composition of Claim 1, further comprising one or more coreactants selected from the group consisting of epoxides, episulfides, oxetanes, thioxetanes, dioxolanes, dioxanes, isocyanates, polyurethanes , polyamides, maleimides, oxazines, oxazolines, (meth) acrylates , acrylamides, and vinyl ethers.

Description:
PHOTOCURABLE ELECTRON DEFICIENT OLEFIN-CONTAINING COMPOSITIONS

BACKGROUND

Field

[0001] This invention relates to photocurable electron deficient olefin-containing compositions, such as those

containing certain 2-cyanoacrylates , 2-cyanopentadienoates , methylidene malonates, and vinylidine cyanide, and photolatent bases. When exposed to radiation in the electromagnetic

spectrum, the compositions show a delay cure property.

Brief Description of Related Technology

[0002] Cyanoacrylate adhesives are known for their fast adhesion and ability to bond a wide variety of substrates. They are marketed as "super glue" type adhesives. They are useful as an all-purpose adhesive since they are a single component adhesive, very economical as only a small amount will do, and generally do not require any equipment to effectuate curing.

[0003] Cyanoacrylates generally are quick-setting materials which cure to clear, hard glassy resins, useful as sealants, coatings, and particularly adhesives for bonding together a variety of substrates [see e.g. H.V. Coover, D.W. Dreifus and J.T. O'Connor, "Cyanoacrylate Adhesives" in Handbook of

Adhesives, 27, 463-77, I. Skeist, ed., Van Nostrand Reinhold, New York, 3rd ed. (1990)].

[0004] Ordinarily, upon contact with substrate materials possessing a surface nucleophile, cyanoacrylate-containing compositions spontaneously polymerize to form a cured material. The cured material exhibits excellent adhesive properties to materials such as metals, plastics, elastomers, fabrics, woods, ceramics and the like. Cyanoacrylate-containing compositions are thus seen as a versatile class of single-component, ambient temperature curing adhesives.

[ 0005] Henkel Corporation has issued a series of U.S.

patents, the focus of which has been a photocurable composition comprising: (a) a 2-cyanoacrylate monomer of the formula H2C— C(CN)—COOR, wherein R is selected from Ci-15 alkyl, alkoxyalkyl, cycloalkyl, alkenyl, aralkyl, aryl, allyl and haloalkyl groups,

(b) a metallocene component, and (c) a photoinitiator component. See U.S. Patent Nos. 5,922,783 (Wojciak), 6,433,036 (Wojciak), 6,726,795 (Wojciak), and 6,906,112 (Wojciak). See also U.S. Patent No. 6,503,959 (Mikuni) .

[ 0006] In some cases, the composition has been activated by radiation in the visible range of the electromagnetic spectrum and the photoinitiator has been selected from dl-camphorquinone, bis (n 5 -2, 4-cyclopentadien-l-yl) -bis [2, 6-difluoro-3- ( lH-pyrrol-1- yl) phenyl] titanium, bis (2, 6-dimethoxybenzoyl-2 , 4, 4-trimethyl pentyl) phosphine oxide, bis (2, 4 , 6-trimethyl benzoyl) phenyl phosphine oxide and combinations thereof.

[ 0007 ] In other cases, the composition has been activated by radiation in the UV range of the electromagnetic spectrum.

Sometimes, the composition has been activated by radiation in the UV and visible range of the electromagnetic spectrum.

[ 0008 ] In a variation, a photocurable composition comprising: (a) a 2-cyanoacrylate component, (b) a photoinitiated radical generating component, and (c) a photoinitiator component other than the photoinitiated radical generating component is

provided. In this variation, the photoinitiator component is embodied by the following structure: χ-

where each of Ar, Ar 1 and Ar 2 are aryl groups, with or without substitution, and X ~ is an anion. See U.S. Patent No. 6,734,221 (Misiak) .

[0009] In another variation, a composition comprising: (a) a 2-cyanoacrylate component, (b) a metallocene component, (c) a photoinitiator component, and (d) a luminescent dye is provided. See U.S. Patent No. 7,064,155 (Wojciak).

[0010] In still another variation, a shelf stable

photocurable composition comprising: (a) a 2-cyanoacrylate component, (b) a metallocene component, and (c) a photoinitiator component comprising the combination of a hydrogen abstraction photoinitiator and a hydrogen donor is provided. See U.S.

Patent No. 6,867,241 (Wojciak) .

[0011] Delayed onset of cure and increased open times have been conferred on RedOx curable compositions. Indeed, Henkel Corporation introduced such a technology when it described -a photolytically induced RedOx curable composition, comprising:

(a) a RedOx curable component selected from vinyl ethers, alkenyl ethers, (meth) acrylates and combinations thereof; (b) a metallocene-containing photoinitiator; (c) a peroxide; and (d) an acidic activator component. See U.S. Patent No. 9,080,084 (Konarski ) .

[0012] While multiple approaches to photocuring

cyanoacrylates have been proposed, and some from Henkel

Corporation are commercially successful, none appear to have a delay onset of cure.

[0013] Until now.

SUMMARY

[0014] Unlike the state of the technology, the present invention provides photocurable electron deficient olefin- containing compositions, such as those containing certain 2- cyanoacrylates , 2-cyanopentadienoates , methylidene malonates, and vinylidine cyanide, and photolatent bases. When exposed to radiation in the electromagnetic spectrum, the compositions show a delay cure property.

[0015] The present invention also provides compositions, together with a stabilizer package comprising at least one of a free radical stabilizer and an anionic stabilizer; and

optionally, one or more additives selected from cure

accelerators, thickeners, thixotropes, tougheners, thermal resistance-conferring agents, or plasticizers .

[0016] The inventive compositions confer benefits over known photocurable cyanoacrylate compositions, including among others: shelf-life stability over prolonged periods of time at ambient temperature when stored in the dark with little to no loss of reactivity; the ability to assemble parts made of opaque (or marginally light transmissive ) materials controlled dosing provides a mechanism for photo-activation that allows assembly of non-UV light transparent substrates; surface insensitivity in that substrates constructed from a wide variety of materials may be bonded; good delay cure features, which permits tuning to either a longer or shorter open time; and improved cure through large depths (or gaps) and independent of the substrate type may be achieved with the inventive compositions.

[0017] Conventional photocurable cyanoacrylate technology struggles to provide these features and thus ordinarily its use is restricted to the assembly of transparent adherends; to small bondline gaps; and the application of a two step activator (or primer) prior to or after application of conventional

cyanoacrylates because they do not cure on neutral (e.g., polyolefin-constructed substrates) or acidic (e.g., phenolic) surfaces .

DETAILED DESCRIPTION

[0018] As noted above, the present invention provides photocurable electron deficient olefin-containing compositions, such as those containing certain 2-cyanoacrylates , 2- cyanopentadienoates, methylidene malonates, and vinylidine cyanide, and photolatent bases. When exposed to radiation in the electromagnetic spectrum, the compositions show a delay cure property .

[0019] The cyanoacrylate may be chosen from one or more of mono-functional 2-cyanoacrylates, di-functional cyanoacrylates, and poly-functional 2-cyanoacrylates.

[0020] More specifically, the cyanoacrylate may be one within the following structure:

where in this connection R 1 is selected from Ci-ιβ alkyl, C2-16 alkoxyalkyl, C3-16 cycloalkyl, C2-16 alkenyl (such as allyl) , C2-16 alkynyl, C5-16 aryl, C7-16 arylalkyl, or C1-16 haloalkyl groups.

[0021] The cyanoacrylate with this structure is selected from methyl cyanoacrylate, ethyl-2-cyanoacrylate, propyl

cyanoacrylates , butyl cyanoacrylates , octyl cyanoacrylates , allyl cyanoacrylate, β-methoxyethyl cyanoacrylate and

combinations thereof.

[0022] The methylidene malonate is one within the following structure :

where in this connection R 2 and R 3 are each independently selected from C1-16 alkyl, alkoxyalkyl, cycloalkyl, alkenyl, aralkyl, aryl, allyl or haloalkyl groups.

[0023] The photolatent base is within the following

structure :

where X is any one of hydrogen, alkyl, hydroxyl, thiol or heteroalkyl, Y is an alkylene linkage, Ra is an alkyl group having from one to four carbon atoms or an alkenyl group having from two to four carbon atoms, Rb is an alkyl group having from one to four carbon atoms or an alkenyl group having from two to four carbon atoms, Rc is an alkyl group having from one to four carbon atoms or an alkenyl group having from two to four carbon atoms, or Rb and Rc taken together form a cyclic ring structure of three to seven ring atoms, which may be interrupted by one or more heteroatoms, and n is 0 or 1.

[ 0024 ] Within this structure are a variety of possible compounds, including carbamates made from the reaction of 2- (2- nitrophenyl ) propyl chloroformate and secondary amines or the reaction of 2- (2-nitrophenyl ) propanol or a-methyl-2-nitrobenzyl alcohols more generally and dialkylcarbamyl halides. For instance, the ortho-nitrophenylpropoxy carbonyl or a-methyl- ortho-nitrobenzyl oxycarbonyl of piperidine,

morpholinediisopropylamine, dicyclohexylamine, diethanolamine , or dimethylamine .

[ 0025 ] More specifically, and particularly desirable are [ (a- methyl-2-nitrobenzyl ) oxycarbonyl] morpholine ("NBM"), [ (2- nitrobenzyl) oxycarbonyl] dimethylamine ("NBDMA"), and 2- (2- nitrophenyl ) propoxycarbonyl piperidine .

[ 0026] Suitable stabilizers include stabilizer packages that may contain one or more of free radical stabilizers and acidic stabilizers .

[0027 ] For example, free radical stabilizers include

hydroquinone, pyrocatechol , resorcinol or derivatives thereof, such as hydroquinone monoethyl ether, or phenols, such as di-t- butylphenol or 2 , 6-di-t-butyl-p-cresol, 2 , 2 ' -methylene-bis- ( 4- methyl- 6-t-butylphenol ) , bisphenol A, dihydroxydiphenylmethane , and styrenized phenols.

[ 0028 ] For example, acidic stabilizers include sulfuric acid, hydrochloric acid, sulfonic acids, such as methane, ethane or higher sulfonic acids, p-toluene sulfonic acid, phosphoric acid or polyphosphoric acids, silyl esters of strong acids, such as trialkyl chlorosilanes, dialkyl dichlorosilanes , alkyl trichlorosilanes, tetrachlorosilane, trialkyl silylsulfonic acids, trialkyl silyl-p-toluene sulfonates, bis-trialkyl silylsulfate and trialkyl silylphosphoric acid esters.

[0029] The amount of either stabilizer used to stabilize the electron deficient olefin prepared by the inventive processes is well known to those of ordinary skill in the art, and may be varied depending on the properties of the resulting composition made from the selected electron deficient olefin.

[0030] The inventive compositions may include one or more additives selected from cure accelerators, thickeners,

thixotropes, tougheners, thermal resistance-conferring agents, or plasticizers .

[0031], The cure accelerators that may be included with the inventive electron deficient olefins to form inventive

compositions include calixarenes and oxacalixarenes , silacrowns, crown ethers, cyclodextrins , poly (ethyleneglycol)

di (meth) acrylates , ethoxylated hydric compounds and combinations thereof .

[0032] Of the calixarenes and oxacalixarenes, many are known, and are reported in the patent literature. See e.g. U.S. Patent Nos. 4,556,700, 4,622,414, 4,636,539, 4,695,615, 4,718,966, and 4,855,461, the disclosures of each of which are hereby expressly incorporated herein by reference.

[0033] For instance, as regards calixarenes, those within the following structure are useful herein:

where in this connection R 1 is alkyl, alkoxy, substituted alkyl or substituted alkoxy; R 2 is H or alkyl; and n is 4, 6 or 8.

[0034] One particularly desirable calixarene is tetrabutyl tetra [2-ethoxy-2-oxoethoxy] calix-4-arene .

[0035] A host of crown ethers are known. For instance, examples which may be used herein include 15-crown-5, 18-crown- 6, dibenzo-18-crown-6, benzo-15-crown-5-dibenzo-24-crown-8 , dibenzo-30-crown-10 , tribenzo-18-crown-6 , asym-dibenzo-22-crown- 6, dibenzo-14-crown- , dicyclohexyl-18-crown-6 , dicyclohexyl-24- crown-8, cyclohexyl-12-crown-4 , 1 , 2-decalyl-15-crown-5 , 1,2-. naphtho-15-crown-5, 3 , 4 , 5-naphtyl-16-crown~5 , 1 , 2-methyl-benzo- 18-crown-6, 1 , 2-methylbenzo-5 , 6-methylbenzo-18-crown-6, 1,2-t- butyl-18-crown-6, 1 , 2-vinylbenzo-15-crown-5 , 1 , 2-vinylbenzo-18- crown-6, 1, 2-t-butyl-cyclohexyl-18-crown-6, asym-dibenzo-22- crown-6 and 1, 2-benzo-l, 4-benzo-5-oxygen-20-crown-7. See U.S. Patent No. 4,837,260 (Sato), the disclosure of which is hereby expressly incorporated here by reference.

[0036] Of the silacrowns, again many are known, and are reported in the literature. For instance, a typical silacrown may be represented within the following structure: Si- ■0

(0CH 2 CH) n where in this connection R 3 and R 4 are organo groups which do not themselves cause polymerization of the cyanoacrylate monomer, R 5 is H or CH 3 and n is an integer of between 1 and 4. Examples of suitable R 3 and R 4 groups are R groups, alkoxy groups, such as methoxy, and aryloxy groups, such as phenoxy. The R 3 and R 4 groups may contain halogen or other substituents , an example being trifluoropropyl . However, groups not suitable as R 4 and R 5 groups are basic groups, such as amino, substituted amino and alkylamino.

[0037] Specific examples of silacrown compounds useful in the inventive compositions include:

dimethylsila-ll-crown-4 ;

dimethylsila-14-crown-5 ;

and dimethylsila-17-crown-6. See e.g. U.S. Patent No. 4,906,317 (Liu) , the disclosure of which is hereby expressly incorporated herein by reference.

[0038] Many cyclodextrins may be used in connection with the present invention. For instance, those described and claimed in U.S. Patent No. 5,312,864 (Wenz) , the disclosure of which is hereby expressly incorporated herein by reference, as hydroxyl group derivatives of an α- , β- or γ-cyclodextrin which is at least partly soluble in the cyanoacrylate would be appropriate choices for use herein as the first accelerator component. [0039] For instance, poly (ethylene glycol) di (meth) acrylates suitable for use herein include those within the following structure:

where n is greater than 3, such as within the range of 3 to 12, with n being 9 as particularly desirable. More specific

examples include PEG 200 DMA (where n is about 4), PEG 400 DMA (where n is about 9), PEG 600 DMA (where n is about 14), and PEG 800 DMA (where n is about 19) , where the number (e.g., 400) represents the average molecular weight of the glycol portion of the molecule, excluding the two methacrylate groups, expressed as grams/mole (i.e., 400 g/mol) . A particularly desirable PEG DMA is PEG 400 DMA.

[0040] And of the ethoxylated hydric compounds (or

ethoxylated fatty alcohols that may be employed) , appropriate ones may be chosen from those within the following structure:

where C m can be a linear or branched alkyl or alkenyl chain, m is an integer between 1 to 30, such as from 5 to 20, n is an integer between 2 to 30, such as from 5 to 15, and R in this connection may be H or alkyl, such as Ci- 6 alkyl.

[0041] When used, the cure accelerator should be included in the compositions in an amount within the range of from about 0.01% to about 10% by weight, with the range of about 0.1 to about 0.5% by weight being desirable, and about 0.4% by weight of the total composition being particularly desirable.

[0042] Other additives may be included with the inventive electron deficient olefins to form inventive compositions to confer additional physical properties, such as improved shock resistance, thickness (for instance, polymethyl methacrylate ) , thixotropy (for instance fumed silica), color, and enhanced resistance to thermal degradation [for instance, maleimide compounds such as N, N' -meta-phenylene bismaleimide ( see U.S. Patent No. 3,988,299 (Malofsky) ) , certain mono, poly or hetero aromatic compounds characterized by at least three substitutions on an aromatic ring thereof, two or more of which being electron withdrawing groups ( see U.S. Patent No. 5,288,794 (Attarwala) ) , certain quinoid compounds (see U.S. Patent No. 5,306,752

(Attarwala)), certain sulfur-containing compounds, such as an anhydrosulfite, a sulfoxide, a sulfite, a sulfonate, a

methanesulfonate or a p-toluenesulfonate (see U.S. Patent No. 5,328,944 (Attarwala)), or certain sulfur-containing compounds, such as a sulfinate, a cyclic sultinate naphthosultone compound substituted with at least one strong electron withdrawing group at least as strongly electron withdrawing as nitro (see U.S. Patent No. 5,424,343 (Attarwala)), and alkylating agents such as polyvinyl benzyl chloride, 4-nitrobenzyl chloride, and

combinations thereof, silylating agents, and combinations thereof (see U.S. Patent No. 6,093,780 (Attarwala)), the

disclosures of each of which are hereby incorporated herein by reference] .

[0043] These other additives may be used in the inventive compositions individually in an amount from about 0.05% to about 20%, such as about 1% to 15%, desirably 5% to 10% by weight, depending of course on the identity of the additive. For instance, and more specifically, citric acid may be used in the inventive compositions in an amount of 5 to 500 ppm, desirably 10 to 100 ppm.

[0044] In addition, the present invention further provides compositions that include a coreactant, such as one selected from epoxides (such as cycloaliphatic epoxies) , episulfides, oxetan . es, thioxetanes, dioxolanes, dioxanes, isocyanates, polyuretahnes , polyamides, maleimides, oxazines, oxazolines, (meth) acrylates, acrylamides, or vinyl ethers.

[0045] The following examples are intended to illustrate but in no way limit the present invention.

EXAMPLES

Example 1 — Synthesis

[ (g-methyl-2-nitrobenzyl) oxycarbonyl]morpholine ( NBM")

Step 1 Step 2

[0046] In this two-step synthesis of [ (a-methyl-2- nitrobenzyl) oxycarbonyl] morpholine ("NBM"), the first step involves the synthesis of the intermediate, -methyl-2- nitrobenzylmethanol ("MNBN") . In order to do so, to a three- neck 1-L reaction flask, open to air and equipped with a magnetic stirring bar, condenser, heating mantle, and

thermocouple, was added 20 g (0.12 mole) of 2-nitroacetophenone (Sigma-Aldrich, 95%) and 260 mL of ethanol (ACS reagent grade, >99.5%). The mixture was stirred until a clear solution was obtained. Then 4.61 g (0.12 mole) of sodium borohydride (Sigma- Aldrich, powder, ≥98%) was added in stages, keeping the reaction temperature below 50 °C. After all the sodium borohydride was added, 200 mL of de-ionized water was then added and the mixture heated to reflux. After five minutes at reflux temperature, the reaction flask was cooled quickly by immersion in an ice-water bath .

[0047] The crude reaction mixture was transferred to a 1-L separatory funnel with 200 mL dichloromethane ( Sigma-Aldrich, reagent grade) and shaken. On standing the mixture separated into two layers and the lower dichloromethane was removed. The residual water layer was then extracted with additional portions of dichloromethane (3 X 200 mL) and the combined dichloromethane extracts were dried over sodium sulfate until a clear solution was obtained (2 hours) . The solution was filtered to remove sodium sulfate and the solvent removed by distillation under reduced pressure to yield the crude intermediate as an amber- colored oil (19.72 g; 98% yield). The crude product was

purified by flash chromatography on a high performance silica column (CombiFlash Rf RediSep 330g Gold) using a hexane/ethyl acetate gradient solvent blend at flow rate of 200 mL/min.

Fractions corresponding to the major component were combined and the solvent removed under reduced pressure to produce MNBN in 85% yield.

[0048] The structure of the product was confirmed by 1 H NMR spectroscopic analysis.

[0049] In the second step, to a three-neck 250-mL flask equipped with a magnetic stir bar, condenser, and thermocouple, was added 19.58 g (0.119 mole) of purified MNBN, 12.02 g of trimethylamine (Sigma Aldrich, >99%), 30 mL dichloromethane (Sigma Aldrich, reagent grade) and 1.45 g (0.0119 mole) of 4- (dimethylamino) pyridine (Sigma Aldrich, >99%) . The solution was stirred at ambient temperature and 17.80 g (0.119 mole) 4- morpholinecarbonyl chloride (Sigma Aldrich, 98%) was added slowly during which time the reaction temperature increased to about 50 °C. The mixture was allowed to cool to ambient

temperature and the stirring was continued. After 24 hours, an infrared spectrum of the mixture indicated the esterification reaction was complete (no further change in IR absorbance peak at 1690 cm "1 ) .

[0050] The reaction mixture was diluted by addition of 170 mL of dichloromethane and washed with 5% solution of hydrochloric acid (3 X 200 mL) . The organic layer was separated, dried over sodium sulfate and filtered. The solvent was removed by distillation under reduced pressure to give a lightly colored oil that was purified by flash chromatography according to the procedure already described. The purified product was obtained in 87% yield and identified as NBM by 1 H NMR spectroscopic analysis.

Example 2 — Synthesis

[ (2-nitrobenzyl) oxycarbonyl] dimethylamine ("NBDMA")

(NBDMA)

[0051] The procedure of Example 1 was repeated using

dimethylaminecarbonyl chloride in place of 4-morpholinecarbonyl chloride. The resulting product, [( 2-nitrobenzyl ) oxycarbonyl ] dimethylamine ("NBDMA") was isolated in 87% yield. Example 3

Photoactivatable Cyanoacrylate/NBM Compositions

[0052] Photoactivatable cyanoacrylate compositions

prepared by blending together, under yellow lights, t

components listed in Table 1.

Table 1

[0053] Composition A, containing 41 part per million (ppm) BF 3 was a clear storage-stable, low viscosity solution product that showed no signs of increasing viscosity (instability) after 3 months storage at ambient temperature in the dark. In contrast, Composition B, with 5 ppm BF 3 , was found to contain a small amount of a gel component that appeared before the photolatent base was dissolved.

[0054] The result indicated that a concentration of BF 3 stabilizer in excess of 5 ppm and less than or equal to 41 ppm provides for adequate shelf-stability of a cyanoacrylate

composition having about 1% by weight NBM in ethyl-2- cyanoacrylate . Composition C, containing 5 ppm BF 3 and without added NBM, was included for comparative purposes. This

composition was stable at ambient temperature over a prolonged period of time. Example 4

UV Light Initiated Curing/Activation of NBM-containing Ethyl 2- Cyanoacrylate Compositions

[0055] Coatings of stabilized uncured Compositions A and C (from Example 3) were prepared by placing 5-6 drops of the composition onto cleaned high density polyethylene substrates with dimensions 25 X 25 mm 2 in area and 5 mm in thickness. The substrates were first cleaned by rinsing the surface with isopropanol and allowing the substrates to dry under air flow. The drops spread on the surface to provide a film approximately 0.5 mm in thickness.

[0056] The coated substrates were then placed 30 cm directly below the medium pressure mercury arc lamp of a Zeta 7216 air cooled UV curing chamber and exposed to UV light for different exposure times. Light intensity measurements were made at the coating surface using a calibrated UV radiometer (UV Power Puck™ supplied by EIT) and were noted as follows: UVA 91 mW/cm 2 ; UVB 76 mW/cm 2 ; UVC 57 mW/cm 2 ; and UVV 186 mW/cm 2 . After exposure, the degree of curing of each coating was qualitatively assessed by examining the state of the irradiated coating and the degree of curing was classified as follows: "No cure" indicating a fully liquid coating with no observable increase in solution

viscosity; "Partial cure" indicating a significant increase in initial solution viscosity or the formation of a tacky polymer; and "fully cured" indicating formation of a dry, hard, solid polymeric coating. Coatings that were not fully cured following UV exposure, were then stored in the dark at ambient temperature and periodically reexamined until curing or no further change in state was observed. The results of are captured below in Table 2. Table 2

[0057] Under the conditions described, Composition A was fully cured following 120 seconds exposure to UV light. In contrast, Composition C (comparative) showed no signs of curing under the same conditions. Coating specimens that were not fully cured after UV exposure period were then placed in the dark at ambient temperature and the curing monitored in the same manner until full cure or no further changes in degree of cure were observed.

[0058] All irradiated samples of Composition A not fully cured after UV exposure were observed to undergo subsequent curing in the dark at ambient temperature to eventually provide fully cured films. The rate of post curing was found to increase as a function of the initial exposure time or dose: 90 minutes full cure time for initial 60 seconds exposure; and 10 minutes full cure time for initial 90 seconds exposure. In contrast, Composition C showed no photo-induced curing under any of the conditions examined. [0059] These results clearly demonstrate that NBM functions as both a photoinitiator and a photoactivating agent for the curing of the cyanoacrylate, which is the basis of the

composition. In the absence of UV light, compositions of cyanoacrylates and NBM and can be maintained as low viscosity liquids for prolonged periods of time. However upon irradiation with UV light, solutions undergo a curing reaction, during which low molecular weight liquid monomers are converted into high molecular weight solid polymers with good adhesive properties.

[0060] The NBM may function either as a photoinitiator or a photo-activating agent depending on the dose of UV radiation delivered during the exposure period. At relatively high doses

(long exposure times) full curing is effected during the

irradiation period and, under such conditions, NBM behaves as a photoinitiator. In contrast, at relatively low doses curing does not take place during exposure, but the adhesive

composition becomes "activated" and undergoes subsequent curing that proceeds more slowly in the dark.

[0061] Generally, exposure to relatively low UV doses (e.g. 1 J/cm 2 ; 10 sec at 100 mW/cm 2 ) activates the compositions such that they remain in a liquid state for several minutes before curing is initiated. This allows the bonding of substrates that are opaque to UV light and provides time to correctly align

substrates before permanent fixtures occur. At higher UV doses (e.g. 3 J/cm 2 / 30 sec at 100 mW/cm 2 ) , full curing can be

accomplished during the irradiation period. The delay or open time can be controlled by adjusting the photolatent

base/stabilizer ratio. Example 5

UV Light Initiated Curing/Activation of NPC-containing Ethyl 2- Cyanoacrylate Compositions

[0062] 2- (2-Nitrophenyl) propoxycarbonyl ("NPC"), prepared as describe in U.S. Patent No. 6,965,040, was also found to be a useful photocuring and photoactivating agent for cyanoacrylates.

[0063] A cyanoacrylate composition containing NPC was

prepared by mixing together, under yellow lights, the components listed in Table 3.

Table 3

[0064] Coatings of Composition D were prepared on

polyethylene substrates as described in Example 4 and exposed to UV light from a Zeta 7730 UV light guide lamp. The samples were placed 1.5 cm directly below the tip of the light guide where the light intensity, measured as described in Example 4, was found to be as follows: UVA 96 mW/cm 2 ; UVB 62 mW/cm 2 ; UVC 0 mW/cm 2 ; and UVV 48 mW/cm 2 . After exposure, the degree of curing of each coating was qualitatively assessed by examining the state of the irradiated coating and the degree of curing was classified as described in Example 4. Coatings that were not fully cured following UV exposure, were then stored in the dark at ambient temperature and periodically reexamined until curing or no further change in state was observed. For comparative purposes, Composition C was tested under the same conditions.

Table 4

[0065] The results, presented in Table 4, clearly demonstrate that NPC, like NBM, is an effective photoinitiator or

photoactivator for cyanoacrylates . These tests also indicate that the UVC component of UV radiation is not required for NPC to be effective. Composition D showed excellent storage

stability with no observable increase in viscosity after 8 weeks storage in dark at room temperature and no loss in photochemical activity .